{"id":"W2317990018","doi":"10.1097/00054725-200912002-00043","title":"Efficacy of certolizumab pegol in Crohnʼs disease patients with secondary failure to infliximab is not affected by concommittant medications","year":2009,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Certolizumab pegol; Concomitant; Infliximab; Clinical endpoint; Internal medicine; Methotrexate; Azathioprine; Bristol-Myers; Mercaptopurine; Crohn's disease; Placebo; Maintenance therapy; Gastroenterology; Clinical trial; Disease; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002484369,0.0004466759,0.001971477,0.0003046066,0.0002822947,0.0006827124,0.0002844718,0.0006798225,0.001243964],"category_scores_gemma":[0.002440481,0.000268305,0.001297787,0.0003282264,0.0005210057,0.0005590594,0.000355582,0.0009226592,0.0002772551],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003222859,"about_ca_system_score_gemma":0.0004313471,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003140126,"about_ca_topic_score_gemma":0.000783376,"domain_scores_codex":[0.9990025,0.0006021773,0.00007659763,0.0001030315,0.00009048726,0.0001252622],"domain_scores_gemma":[0.9977558,0.000795707,0.0006817743,0.0001324785,0.0001096818,0.0005245294],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7415155,0.006123455,0.1553859,0.0008051095,0.001495365,0.0006406424,0.0001812354,0.0007832561,0.0199821,0.0000693138,0.0006946895,0.07232345],"study_design_scores_gemma":[0.1673,0.3912149,0.4268951,0.0001576993,0.001476027,0.001917168,0.0001181318,0.001645555,0.005892179,0.0001302696,0.003187742,0.00006528669],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974451,0.001797406,0.0000945905,0.00005394818,0.00002686933,0.00009189751,0.0001100715,0.000008174014,0.0003719261],"genre_scores_gemma":[0.998879,0.0003092195,0.0001543457,0.0000888029,0.00005561841,0.00005782898,0.0002593233,0.00000351548,0.0001922501],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002484369,"threshold_uncertainty_score":0.01313877,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.003105816489238441,"score_gpt":0.2179526808592874,"score_spread":0.214846864370049,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}